|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
protein:increased expression:blood, lymphocyte |
RGD |
PMID:19484671 |
RGD:4890020 |
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
|
ISO |
|
RGD |
PMID:18931056 |
RGD:5128825 |
NCBI chrNW_004936501:3,400,971...3,467,061
Ensembl chrNW_004936501:3,401,285...3,470,460
|
|
G |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
no_association |
ISO |
|
RGD |
PMID:16008680 PMID:19771478 |
RGD:5128831 RGD:5128835 |
NCBI chrNW_004936570:1,315,192...1,322,719
|
|
G |
Acsl3 |
acyl-CoA synthetase long chain family member 3 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:19221603 |
RGD:13831295 |
NCBI chrNW_004936569:4,774,602...4,842,906
Ensembl chrNW_004936569:4,774,542...4,844,494
|
|
G |
Ada |
adenosine deaminase |
susceptibility |
ISO |
DNA:polymorphisms (human) |
RGD |
PMID:16754522 |
RGD:5128848 |
NCBI chrNW_004936530:2,217,713...2,224,070
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
susceptibility disease_progression no_association |
ISO |
DNA:polymorphism: :p.M764T (human) mRNA:increased expression:lung DNA:SNPs: :multiple (human) mRNA:increased expression:bronchus DNA:SNPs:introns,exon:7575G>A, 11188A>T, 12433T>C (human) DNA:SNPs (human) |
RGD |
PMID:16893396 PMID:17339047 PMID:17961406 PMID:18778489 PMID:19635592 PMID:19940503 More...
|
RGD:4145359 RGD:4145360 RGD:4145378 RGD:4145379 RGD:4145380 RGD:4145382 |
NCBI chrNW_004936485:15,005,329...15,018,063
Ensembl chrNW_004936485:15,007,485...15,017,497
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
severity |
ISO |
mRNA:increased expression:respiratory tract mRNA:increased expression:bronchus |
RGD |
PMID:17339047 PMID:19373511 PMID:20194813 |
RGD:4145380 RGD:5128872 RGD:5128878 |
NCBI chrNW_004936486:19,389,925...19,403,577
Ensembl chrNW_004936486:19,391,324...19,402,332
|
|
G |
Adcy2 |
adenylate cyclase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004936643:47,830...338,891
Ensembl chrNW_004936643:47,837...339,007
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21059121 |
|
NCBI chrNW_004936478:7,278,081...7,322,970
Ensembl chrNW_004936478:7,278,147...7,318,458
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
|
RGD |
PMID:19168697 |
RGD:5686821 |
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
protein:increased expression:bronchus DNA:SNPs: :1405C>T (human) |
RGD |
PMID:17959644 PMID:19019667 PMID:20400685 |
RGD:4145444 RGD:4890386 RGD:5129097 |
NCBI chrNW_004936567:1,430,128...1,508,626
Ensembl chrNW_004936567:1,429,817...1,462,532
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
mRNA:decreased expression:aorta DNA:SNP (human) |
RGD |
PMID:16339780 PMID:17293374 PMID:18310516 PMID:19019667 |
RGD:4890366 RGD:4890380 RGD:4890385 RGD:4890386 |
NCBI chrNW_004936619:597,970...618,564
Ensembl chrNW_004936619:608,441...616,779
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Beta-2-adrenoreceptor agonist, reduced response to DNA:SNP: :-1023A>G (human) |
ClinVar RGD |
PMID:8383511 PMID:15284533 PMID:16596417 PMID:19638684 |
RGD:4145081 |
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
treatment onset |
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:lung (rat) |
RGD CTD |
PMID:21920897 PMID:23304218 PMID:33075463 |
RGD:6767554 RGD:7244279 |
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G |
Agtr1 |
angiotensin II receptor type 1 |
|
ISO |
|
RGD |
PMID:19080339 |
RGD:5147457 |
NCBI chrNW_004936519:6,831,096...6,873,977
Ensembl chrNW_004936519:6,831,096...6,873,985
|
|
G |
Agtr2 |
angiotensin II receptor type 2 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19080339 |
RGD:5147457 |
NCBI chrNW_004936479:13,252,678...13,255,570
Ensembl chrNW_004936479:13,252,678...13,255,570
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9600491 PMID:11506308 |
|
NCBI chrNW_004936558:4,362,693...4,387,705
Ensembl chrNW_004936558:4,362,654...4,390,414
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:18692885 PMID:19628725 |
RGD:5509605 RGD:5509784 |
NCBI chrNW_004936677:3,232,183...3,241,307
Ensembl chrNW_004936677:3,232,183...3,241,253
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
no_association treatment severity |
ISO |
DNA:polymorphism:promoter (human) DNA:repeat:promoter (human) |
RGD OMIM |
PMID:10369259 PMID:12911785 PMID:16364163 PMID:20128419 |
RGD:4890407 RGD:4890415 RGD:5147465 RGD:734557 |
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
no_association susceptibility |
ISO |
DNA:repeat:promoter:-169(A)21 (human) DNA:substitution, repeat:promoter:-336G>A, -169(A)19-23 (human) DNA:polymorphism:promoter (human) mRNA:increased expression:blood, leukocyte DNA:SNPs (human) protein:increased expression:lung DNA:SNP: :rs10507391 (human) DNA:polymorphisms:intron:IVS2+12C>A, IVS2+105T>C (human) |
RGD |
PMID:8879219 PMID:9642160 PMID:10527888 PMID:11035107 PMID:12911785 PMID:15784112 PMID:18547289 PMID:20067482 PMID:20128419 More...
|
RGD:4890405 RGD:4890407 RGD:4890409 RGD:4890422 RGD:5147462 RGD:5147464 RGD:5147465 RGD:5147466 RGD:5147467 |
NCBI chrNW_004936472:25,477,094...25,502,823
Ensembl chrNW_004936472:25,477,010...25,502,840
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14621078 |
RGD:6904149 |
NCBI chrNW_004936487:3,399,792...3,412,088
|
|
G |
Ang |
angiogenin |
severity |
ISO |
protein:increased expression:sputum |
RGD |
PMID:16478840 |
RGD:6892719 |
NCBI chrNW_004936880:39,372...40,070
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:22092555 |
RGD:7421657 |
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
|
|
G |
Areg |
amphiregulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15696081 |
|
NCBI chrNW_004936598:1,276,599...1,283,612
Ensembl chrNW_004936598:1,274,565...1,283,746
|
|
G |
Arg2 |
arginase 2 |
susceptibility severity |
ISO |
DNA:SNPs (human) CTD Direct Evidence: marker/mechanism DNA:SNP: :rs3742879, rs17249437 (human) mRNA:increased expression:lung (mouse) |
RGD CTD |
PMID:12813022 PMID:16387594 PMID:19281908 PMID:20124949 |
RGD:4143187 RGD:5129205 RGD:5129207 |
NCBI chrNW_004936495:11,004,296...11,045,467
Ensembl chrNW_004936495:11,004,176...11,045,472
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18357729 |
|
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
onset |
ISO |
protein:increased expression:blood, eosinophil DNA:polymorphism:exon (human) |
RGD |
PMID:8856156 PMID:11517947 PMID:14727005 PMID:19038786 |
RGD:4890454 RGD:4890456 RGD:4891028 RGD:4891042 |
NCBI chrNW_004936604:548,844...551,031
Ensembl chrNW_004936604:548,847...549,956
|
|
G |
Bdnf |
brain derived neurotrophic factor |
severity susceptibility |
ISO |
protein:increased expression:plasma protein:decreased expression:blood, eosinophil DNA:polymorphisms: :p.V66M, -270C>T (human) DNA:polymorphisms: :p.V66M (rs6265) (human) DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) |
RGD |
PMID:11737043 PMID:12752594 PMID:17584309 PMID:19895626 PMID:20874832 PMID:21723144 More...
|
RGD:4891063 RGD:4891067 RGD:4891117 RGD:4891122 RGD:4891123 RGD:8655967 |
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8429434 |
|
NCBI chrNW_004936580:5,480,023...5,482,288
Ensembl chrNW_004936580:5,481,355...5,482,155
|
|
G |
Bmpr1b |
bone morphogenetic protein receptor type 1B |
|
ISO |
protein:decreased expression:bronchus |
RGD |
PMID:18292470 |
RGD:5129470 |
NCBI chrNW_004936687:2,346,601...2,595,283
Ensembl chrNW_004936687:2,503,777...2,597,522
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
ISO |
protein:decreased expression:bronchus |
RGD |
PMID:18292470 |
RGD:5129470 |
NCBI chrNW_004936726:1,543,263...1,711,422
Ensembl chrNW_004936726:1,543,245...1,704,541
|
|
G |
C3 |
complement C3 |
severity |
ISO |
DNA:SNPs: :multiple (human) DNA:SNP:intron:rs11569562 (human) protein:increased expression:serum protein:increased expression:respiratory system fluid/secretion Interaction with IL4RA DNA:SNP: :4896C>T (human) |
RGD |
PMID:11591733 PMID:15278436 PMID:16355111 PMID:18566738 PMID:20395963 PMID:20402389 PMID:20589464 PMID:20802484 More...
|
RGD:5129501 RGD:5129505 RGD:5129512 RGD:5129517 RGD:5129519 RGD:5129537 RGD:5129538 RGD:5129681 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
C3ar1 |
complement C3a receptor 1 |
severity |
ISO |
mRNA:increased expression:lung protein:increased expression:lung, leukocyte |
RGD |
PMID:15278436 PMID:15940127 PMID:17544263 PMID:20045013 PMID:20802484 |
RGD:5129512 RGD:5129560 RGD:5129561 RGD:5129681 RGD:5129686 |
NCBI chrNW_004936892:347,547...355,143
Ensembl chrNW_004936892:347,842...349,296
|
|
G |
C5 |
complement C5 |
severity |
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:10973279 PMID:11591795 PMID:15278436 PMID:20143644 PMID:20802484 |
RGD:1600651 RGD:5129512 RGD:5129681 RGD:5129706 RGD:5130158 |
NCBI chrNW_004936487:9,391,774...9,474,168
Ensembl chrNW_004936487:9,391,804...9,474,159
|
|
G |
C5ar1 |
complement C5a receptor 1 |
severity |
ISO |
protein:increased expression:lung, leukocyte protein:increased expression:respiratory tract |
RGD |
PMID:15940127 PMID:16511606 PMID:17544263 PMID:20802484 |
RGD:5129560 RGD:5129561 RGD:5129681 RGD:5130166 |
NCBI chrNW_004936664:1,026,216...1,033,438
Ensembl chrNW_004936664:1,032,304...1,033,374
|
|
G |
Card11 |
caspase recruitment domain family member 11 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma |
RGD ClinVar |
PMID:16751370 PMID:18323416 PMID:23027925 PMID:23129749 PMID:25352053 PMID:25741868 PMID:26861442 PMID:28492532 PMID:28824638 PMID:29472930 More...
|
RGD:11100037 |
NCBI chrNW_004936823:580,438...621,298
Ensembl chrNW_004936823:581,955...621,208
|
|
G |
Carm1 |
coactivator associated arginine methyltransferase 1 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004936659:1,071,883...1,120,917
Ensembl chrNW_004936659:1,090,164...1,123,920
|
|
G |
Cat |
catalase |
severity |
ISO |
protein:decreased activity:respiratory system fluid/secretion DNA:polymorphism:promoter:-21A>T (human) protein:increased expression:erythrocyte CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-262C>T (human) |
RGD CTD |
PMID:16622028 PMID:18048809 PMID:19373626 PMID:19475625 |
RGD:5130751 RGD:5130753 RGD:5130856 RGD:5130867 |
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20455898 |
RGD:4891420 |
NCBI chrNW_004936538:781,687...784,199
Ensembl chrNW_004936538:781,687...784,199
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion mRNA:increased expression:lung |
RGD |
PMID:11160256 PMID:15947487 PMID:15993846 PMID:20074456 PMID:20237293 |
RGD:2306304 RGD:4145486 RGD:4145487 RGD:4145513 RGD:4145603 |
NCBI chrNW_004936475:9,475,013...9,476,326
Ensembl chrNW_004936475:9,474,961...9,476,398
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
protein:increased expression:bronchus submucosa, mast cell |
RGD |
PMID:16959919 |
RGD:5130911 |
NCBI chrNW_004936524:2,765,271...2,767,259
Ensembl chrNW_004936524:2,765,267...2,767,385
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
associated with Allergic Rhinitis;protein:increased expression:serum protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:18422729 PMID:22469443 |
RGD:7483597 RGD:7483618 |
NCBI chrNW_004936525:8,238,128...8,240,974
Ensembl chrNW_004936525:8,237,831...8,240,974
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion mRNA:increased expression:lung mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion |
RGD |
PMID:10384142 PMID:15993846 PMID:18316417 PMID:18684970 |
RGD:2306304 RGD:4145489 RGD:4891474 RGD:4891475 |
NCBI chrNW_004936475:9,432,505...9,436,240
Ensembl chrNW_004936475:9,432,505...9,436,240
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
susceptibility |
ISO |
protein:increased expression:plasma DNA:SNPs: :304C>A, 1272A>G (human) protein:increased expression:respiratory system fluid/secretion DNA:SNP: :1265A>G (human) DNA:SNPs: :179T>C, 275C>T (human) |
RGD |
PMID:12761043 PMID:12952266 PMID:15207712 PMID:16304252 PMID:17060636 PMID:17548626 PMID:18712274 More...
|
RGD:4891483 RGD:4891484 RGD:4891485 RGD:4891495 RGD:4891496 RGD:5130930 RGD:5130932 |
NCBI chrNW_004936543:2,400,743...2,403,558
Ensembl chrNW_004936543:2,400,768...2,403,217
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
treatment |
ISO |
protein:increased expression:plasma DNA:SNPs: :77C>T, 716A>G, 1579G>A (human) DNA:SNPs: :77C>T, 2497T>G (human) |
RGD |
PMID:15207712 PMID:16304252 PMID:18712274 PMID:25399816 PMID:25530546 |
RGD:11081163 RGD:11087575 RGD:4891483 RGD:4891495 RGD:5130930 |
NCBI chrNW_004936543:2,414,948...2,416,922
Ensembl chrNW_004936543:2,414,850...2,416,953
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
|
ISO |
|
RGD |
PMID:19541356 |
RGD:5130899 |
NCBI chrNW_004936524:2,743,106...2,743,759
Ensembl chrNW_004936524:2,743,068...2,743,746
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16290206 |
RGD:4892195 |
NCBI chrNW_004936480:18,819,012...18,824,981
Ensembl chrNW_004936480:18,810,406...18,824,894
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:lung, secretion (mouse) CTD Direct Evidence: marker/mechanism DNA:transition:5' utr:-403G>A (human) protein:increased expression:smooth muscle cell |
RGD CTD |
PMID:8534483 PMID:18208670 PMID:20092989 PMID:20430255 |
RGD:2307112 RGD:4891381 RGD:4891430 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, neutrophil DNA:SNP:exon:51T>C (human) |
RGD |
PMID:16978084 PMID:17145927 PMID:18699933 PMID:19017998 PMID:19657453 PMID:20134116 PMID:20220260 More...
|
RGD:1601020 RGD:4145618 RGD:4145623 RGD:4145632 RGD:4145633 RGD:4145638 RGD:4145646 |
NCBI chrNW_004936596:223,660...224,739
Ensembl chrNW_004936596:223,660...224,739
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chrNW_004936473:23,321,167...23,323,075
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:19917684 |
RGD:8549811 |
NCBI chrNW_004936489:16,669,297...16,689,451
Ensembl chrNW_004936489:16,669,297...16,689,451
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
protein:increased expression:lung, dendritic cell (mouse) |
RGD |
PMID:19917684 |
RGD:8549811 |
NCBI chrNW_004936490:15,575,764...15,579,766
Ensembl chrNW_004936490:15,575,764...15,579,757
|
|
G |
Ccr8 |
C-C motif chemokine receptor 8 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chrNW_004936473:28,590,471...28,591,538
Ensembl chrNW_004936473:28,590,471...28,591,538
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
|
ISO |
mRNA, protein:increased expression:blood, mature NK T cell |
RGD |
PMID:16210593 |
RGD:5130925 |
NCBI chrNW_004936695:55,788...59,251
Ensembl chrNW_004936695:55,788...59,251
|
|
G |
Cd14 |
CD14 molecule |
no_association susceptibility severity |
ISO |
DNA:polymorphism:promoter:c. -159C>T (human) DNA:SNPs: : protein:increased expression:serum CTD Direct Evidence: marker/mechanism protein:increased expression:serum|DNA:polymorphism:promoter:c. -159C>T (human) DNA:polymorphism:promoter:c. -260C>T (human) |
RGD CTD |
PMID:15741437 PMID:15940135 PMID:16387800 PMID:17607003 PMID:18312481 PMID:19096003 More...
|
RGD:4144208 RGD:4144228 RGD:4144813 RGD:4144814 RGD:4144815 |
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
|
|
G |
Cd274 |
CD274 molecule |
treatment |
ISO |
associated with Chlamydia pneumonia |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chrNW_004936539:132,870...145,288
Ensembl chrNW_004936539:132,868...143,602
|
|
G |
Cd28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21356099 |
RGD:5131612 |
NCBI chrNW_004936631:335,411...363,407
Ensembl chrNW_004936631:335,411...363,407
|
|
G |
Cd40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:19159017 PMID:19220210 PMID:20205594 PMID:20941750 |
RGD:4144188 RGD:4892277 RGD:5132272 RGD:8547792 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd40lg |
CD40 ligand |
severity |
ISO |
|
RGD |
PMID:9502776 |
RGD:11352238 |
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:21051864 PMID:21352203 PMID:21440530 |
RGD:5132619 RGD:5132620 RGD:5132621 |
NCBI chrNW_004936536:6,462,080...6,483,450
|
|
G |
Cd86 |
CD86 molecule |
treatment |
ISO |
protein:increased expression:blood, B cell (human) protein:increased expression:lung, dendritic cell (rat) protein:increased expression:lung, alveolar macrophage (mouse) DNA:snp:exon:p.I179V rs2681417 (human) |
RGD |
PMID:9449507 PMID:9551945 PMID:17513529 PMID:20668438 PMID:20941750 PMID:25344652 More...
|
RGD:11354965 RGD:4892199 RGD:4892202 RGD:4892277 RGD:4892280 RGD:4892555 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
|
RGD |
PMID:21540309 |
RGD:5132878 |
NCBI chrNW_004936475:18,990,529...19,065,954
Ensembl chrNW_004936475:18,990,474...19,067,203
|
|
G |
Cdhr3 |
cadherin related family member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004936479:17,910,443...17,975,797
Ensembl chrNW_004936479:17,910,570...17,966,225
|
|
G |
Cftr |
CF transmembrane conductance regulator |
susceptibility |
ISO |
DNA:deletion: :p.F508del(human) |
RGD |
PMID:20298391 |
RGD:4140387 |
NCBI chrNW_004936589:1,565,933...1,719,208
|
|
G |
Chat |
choline O-acetyltransferase |
|
ISO |
Protein:decreased expression:lung epithelium |
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004936728:653,654...702,433
Ensembl chrNW_004936728:654,638...700,213
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 7 |
OMIM ClinVar |
PMID:18403759 |
|
NCBI chrNW_004936567:1,411,080...1,418,332
Ensembl chrNW_004936567:1,411,037...1,418,801
|
|
G |
Chia |
chitinase acidic |
no_association |
ISO |
mRNA:increased expression:lung (mouse) DNA:snps:multiple (human) DNA:snps:5' utr, cds:multiple (human) mRNA:increased expression:lung, epithelial cell (human) |
RGD |
PMID:14734765 PMID:15192232 PMID:16179638 PMID:19548841 PMID:20226308 |
RGD:4985150 RGD:4990463 RGD:4996473 RGD:5024921 RGD:5024922 |
NCBI chrNW_004939091:1,194...12,273
Ensembl chrNW_004939091:1,190...12,272
|
|
G |
Chml |
CHM like Rab escort protein |
|
ISO |
|
RGD |
PMID:18343558 |
RGD:5133238 |
NCBI chrNW_004936526:8,833,921...8,844,484
|
|
G |
Chrm1 |
cholinergic receptor muscarinic 1 |
|
ISO |
|
RGD |
PMID:16931638 |
RGD:5133416 |
NCBI chrNW_004936581:387,939...400,740
Ensembl chrNW_004936581:387,705...400,740
|
|
G |
Chrm2 |
cholinergic receptor muscarinic 2 |
|
ISO |
DNA:SNP: :rs6962027 (human) |
RGD |
PMID:19308904 |
RGD:5509586 |
NCBI chrNW_004936592:1,396,939...1,525,255
Ensembl chrNW_004936592:1,521,547...1,522,947
|
|
G |
Chrm3 |
cholinergic receptor muscarinic 3 |
severity |
ISO |
|
RGD |
PMID:18348887 PMID:20394512 |
RGD:5133437 RGD:5133438 |
NCBI chrNW_004936484:13,953,141...14,373,174
Ensembl chrNW_004936484:13,954,887...13,956,659
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:21496385 |
RGD:5133703 |
NCBI chrNW_004936636:33,933...78,990
Ensembl chrNW_004936636:33,673...79,194
|
|
G |
Clca1 |
chloride channel accessory 1 |
susceptibility |
ISO |
DNA:SNPs (human) |
RGD |
PMID:11296262 PMID:15318163 PMID:17898169 |
RGD:4145653 RGD:4145656 RGD:4145661 |
NCBI chrNW_004936865:155,284...188,988
|
|
G |
Cldn18 |
claudin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27215490 |
|
NCBI chrNW_004936540:373,889...401,535
Ensembl chrNW_004936540:373,889...401,535
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
DNA:SNP: :RS242941 (human) DNA:SNPs: :rs1876828, rs242939, rs242941 (human) |
RGD |
PMID:16113459 PMID:19663668 |
RGD:5147485 RGD:5147488 |
NCBI chrNW_004936541:2,288,847...2,333,129
Ensembl chrNW_004936541:2,288,841...2,331,689
|
|
G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:18408560 |
RGD:5130938 |
NCBI chrNW_004936478:6,901,098...6,947,719
Ensembl chrNW_004936478:6,899,017...6,947,790
|
|
G |
Crp |
C-reactive protein |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21140796 |
RGD:5131288 |
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G |
Csf2 |
colony stimulating factor 2 |
severity |
ISO |
protein:increased expression:lung protein:increased expression:sputum |
RGD |
PMID:9717963 PMID:19213775 PMID:20405019 |
RGD:10449521 RGD:5131473 RGD:5131476 |
NCBI chrNW_004936647:3,081,896...3,083,864
Ensembl chrNW_004936647:3,081,896...3,083,864
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor subunit beta |
|
ISO |
|
RGD |
PMID:17145927 |
RGD:1601020 |
NCBI chrNW_004936492:3,929,589...3,974,070
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20405019 PMID:21396376 |
RGD:5131473 RGD:5133731 |
NCBI chrNW_004936490:15,142,526...15,146,375
Ensembl chrNW_004936490:15,142,808...15,144,487
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
severity treatment no_association |
ISO |
DNA:SNPs: :multiple (human) protein:increased expression:serum DNA:SNP: :rs3087243 (human) DNA:polymorphisms:promoter, exon:-318C>T 49A>G (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, exon:-1147C>T, -318C>T, 49A>G (human) DNA:polymorphism:promoter:-318C>T (human) |
RGD CTD |
PMID:11726402 PMID:12114354 PMID:12956753 PMID:15316504 PMID:15871446 PMID:16677453 PMID:16708626 PMID:16926542 PMID:17237396 PMID:17469155 PMID:18699801 PMID:19895365 PMID:28807506 More...
|
RGD:11344922 RGD:4891510 RGD:4891514 RGD:4891516 RGD:4891517 RGD:4891519 RGD:4891521 RGD:4891522 RGD:4891526 RGD:4891527 RGD:4891528 RGD:4891529 |
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
|
|
G |
Ctnna3 |
catenin alpha 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19187332 |
|
NCBI chrNW_004936521:10,482,434...10,936,554
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:14657873 |
RGD:4891906 |
NCBI chrNW_004936475:9,443,851...9,454,715
Ensembl chrNW_004936475:9,443,733...9,455,062
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
no_association |
ISO |
DNA:polymorphisms: :p.V249I, p.T280M (human) DNA:SNPs: :p.V249I, rs2669849 (human) |
RGD |
PMID:17082760 PMID:17505143 PMID:21037587 |
RGD:4891882 RGD:4891895 RGD:4891904 |
NCBI chrNW_004936473:28,508,726...28,535,640
Ensembl chrNW_004936473:28,510,523...28,535,627
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:11994485 PMID:16602032 PMID:17302903 |
RGD:5135439 RGD:5135452 RGD:5135457 |
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21150878 |
|
NCBI chrNW_004936597:2,746,415...2,754,169
Ensembl chrNW_004936597:2,746,296...2,754,716
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15210824 |
RGD:5135447 |
NCBI chrNW_004936676:33,580...40,323
Ensembl chrNW_004936676:32,128...40,329
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
susceptibility severity |
ISO |
DNA:SNP:intron:IVS1+234G>A (human) protein:decreased expression:respiratory system fluid/secretion, T cell |
RGD |
PMID:16043121 PMID:16548899 PMID:17641057 PMID:18094012 |
RGD:4892088 RGD:5135484 RGD:5143932 RGD:5143934 |
NCBI chrNW_004936762:66,636...69,694
Ensembl chrNW_004936762:66,636...69,373
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
severity no_association |
ISO |
mRNA, protein:increased expression:respiratory system mucosa DNA:SNPs:promoter:-634C>T, -475A>C, -336A>G (human) DNA:SNPs:promoter, exon:multiple (human) DNA:SNP: :927T>C (human) |
RGD |
PMID:8087328 PMID:11591188 PMID:16123393 PMID:16387808 PMID:16630147 PMID:16771777 PMID:16776674 PMID:17153879 PMID:17689528 More...
|
RGD:4781449 RGD:4781742 RGD:4782072 RGD:4784257 RGD:4843543 RGD:4847129 RGD:4848936 RGD:4888514 RGD:4889116 |
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:polymorphism: :-1220A>C (human) DNA:polymorphism: :601A>G (human) |
RGD |
PMID:15454733 PMID:15475736 |
RGD:5144002 RGD:5144003 |
NCBI chrNW_004936565:1,917,970...1,919,027
|
|
G |
Dcn |
decorin |
|
ISO |
|
RGD |
PMID:16387756 |
RGD:2311423 |
NCBI chrNW_004936507:7,887,259...7,923,055
Ensembl chrNW_004936507:7,884,654...7,922,961
|
|
G |
Defb1 |
defensin beta 1 |
susceptibility |
ISO |
DNA:SNPs:5' utr:g.-52G>A, g.-44C>G, g.-20G>A (human) DNA:SNP: :-1816 T>C (human) |
RGD |
PMID:15696078 PMID:16435024 |
RGD:4892254 RGD:4892263 |
NCBI chrNW_004936615:4,780,229...4,790,516
|
|
G |
Dnah5 |
dynein axonemal heavy chain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004936665:2,267,272...2,545,765
Ensembl chrNW_004936665:2,314,175...2,545,579
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA,mRNA:hypermethylation,decreased expression:promoter,respiratory tract: |
CTD RGD |
PMID:23196709 PMID:23423710 |
RGD:9588646 |
NCBI chrNW_004936659:520,181...565,496
Ensembl chrNW_004936659:520,493...565,416
|
|
G |
Dpp10 |
dipeptidyl peptidase like 10 |
|
ISO |
DNA:SNP:exon (human) DNA:SNP: :rs10208402 (human) protein:increased expression:bronchus DNA:SNPs (human) |
RGD |
PMID:14566338 PMID:17967935 PMID:19672052 PMID:21103062 |
RGD:4889866 RGD:4892275 RGD:4892276 RGD:4892278 |
NCBI chrNW_004936469:53,950,034...54,548,724
Ensembl chrNW_004936469:53,948,570...54,548,747
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
|
ISO |
|
RGD |
PMID:21255010 |
RGD:5128488 |
NCBI chrNW_004936588:2,420,859...2,425,473
Ensembl chrNW_004936588:2,421,934...2,425,207
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
Severe Persistent Allergic Asthma; protein:increased secretion:lung (human) DNA:transition:intron:g.4124T>C (human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:11668616 PMID:16981460 PMID:20588001 |
RGD:4144869 RGD:4144895 |
NCBI chrNW_004936534:885,489...892,292
Ensembl chrNW_004936534:885,287...891,772
|
|
G |
Ednra |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:17448648 PMID:18632188 |
RGD:4892288 RGD:4892322 |
NCBI chrNW_004936535:1,950,117...2,005,786
Ensembl chrNW_004936535:1,949,941...2,005,910
|
|
G |
Ednrb |
endothelin receptor type B |
|
ISO |
mRNA:increased expression:bronchus, smooth muscle cell DNA:polymorphism (human) |
RGD |
PMID:15245576 PMID:17470272 PMID:18632188 |
RGD:4892288 RGD:4892321 RGD:4892324 |
NCBI chrNW_004936511:3,446,864...3,478,434
Ensembl chrNW_004936511:3,446,839...3,478,434
|
|
G |
Egfr |
epidermal growth factor receptor |
severity |
ISO |
protein:increased expression:lung epithelium (mouse) protein:increased expression:lung epithelium (rat) protein:increased expression:bronchial epithelium (human) |
RGD |
PMID:12580917 PMID:19954006 PMID:21072743 PMID:21224214 |
RGD:5131468 RGD:5131633 RGD:5131642 RGD:5131870 |
NCBI chrNW_004936678:365,005...560,546
Ensembl chrNW_004936678:365,834...436,528
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) mRNA:increased expression:bronchoalveolar lavage cell (human) |
RGD |
PMID:11254538 PMID:18507785 PMID:18774390 |
RGD:5130915 RGD:5131985 RGD:5131993 |
NCBI chrNW_004936531:7,625,956...7,629,041
Ensembl chrNW_004936531:7,625,892...7,629,749
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
no_association |
ISO |
|
RGD |
PMID:11281413 PMID:12774215 |
RGD:5129157 RGD:5129158 |
NCBI chrNW_004936559:3,924,185...3,981,907
Ensembl chrNW_004936559:3,924,185...3,983,028
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
susceptibility |
ISO |
DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human) |
RGD |
PMID:17711870 |
RGD:4889407 |
NCBI chrNW_004936526:2,589,254...2,652,831
Ensembl chrNW_004936526:2,614,059...2,653,286
|
|
G |
Epx |
eosinophil peroxidase |
disease_progression severity |
ISO |
protein:increased activity:sputum,nasal,pharyngeal mucosa |
RGD |
PMID:12199967 PMID:20813885 PMID:26645423 |
RGD:11574908 RGD:13506891 RGD:13506892 |
NCBI chrNW_004936490:4,876,857...4,887,275
Ensembl chrNW_004936490:4,876,877...4,887,275
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
mRNA:decreased expression:lung (rat) |
RGD |
PMID:18375789 |
RGD:8694127 |
NCBI chrNW_004936495:7,956,168...8,018,356
Ensembl chrNW_004936495:7,956,766...8,004,357
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:plasma associated with Rhinosinusitis, associated with Nasal Polyps;protein:increased expression:nasal mucus |
RGD |
PMID:21658190 PMID:21711961 |
RGD:5147753 RGD:5147783 |
NCBI chrNW_004936562:2,371,725...2,388,617
Ensembl chrNW_004936562:2,372,044...2,388,650
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:19864598 |
RGD:4892589 |
NCBI chrNW_004936549:142,281...153,575
Ensembl chrNW_004936549:141,512...153,602
|
|
G |
F7 |
coagulation factor VII |
treatment |
ISO |
|
RGD |
PMID:24523826 |
RGD:11040539 |
NCBI chrNW_004936472:505,751...515,375
Ensembl chrNW_004936472:505,751...514,339
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
mRNA:increased expression:eosinophil |
RGD |
PMID:16337971 |
RGD:1600350 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
severity |
ISO |
Fatal asthma subjects Asthma symptoms persistent despite steroids |
RGD |
PMID:20937062 PMID:21388666 |
RGD:5128711 RGD:5128717 |
NCBI chrNW_004936740:1,201,370...1,206,871
|
|
G |
Fcgr2a |
Fc fragment of IgG receptor IIa |
|
ISO |
protein:increased expression:alveolar macrophage |
RGD |
PMID:9117017 |
RGD:5147982 |
NCBI chrNW_004937131:15,542...22,099
|
|
G |
Fcgr2b |
Fc fragment of IgG receptor IIb |
|
ISO |
|
RGD |
PMID:20179765 |
RGD:11344929 |
NCBI chrNW_004937131:80,014...96,114
|
|
G |
Fga |
fibrinogen alpha chain |
treatment |
ISO |
|
RGD |
PMID:24523826 |
RGD:11040539 |
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
|
ISO |
ClinVar Annotator: match by term: Asthma |
ClinVar |
|
|
NCBI chrNW_004936476:23,611,166...23,702,283
Ensembl chrNW_004936476:23,640,355...23,700,314
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27633092 PMID:27965764 PMID:28944907 PMID:29317916 |
RGD:38548920 RGD:38549365 |
NCBI chrNW_004936721:1,118,376...1,125,282
Ensembl chrNW_004936721:1,118,782...1,132,308
|
|
G |
Gata3 |
GATA binding protein 3 |
|
ISO |
|
RGD |
PMID:9949310 PMID:18186587 |
RGD:5128802 RGD:5128803 |
NCBI chrNW_004936484:6,780,692...6,800,883
Ensembl chrNW_004936484:6,780,692...6,800,966
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
protein, mRNA:increased expression:bronchoalveolar lavage fluid: |
RGD |
PMID:21169467 |
RGD:5509920 |
NCBI chrNW_004936598:3,220,029...3,256,091
Ensembl chrNW_004936598:3,219,991...3,261,629
|
|
G |
Gsdmb |
gasdermin B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004936490:15,058,009...15,066,781
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
DNA:polymorphism |
RGD |
PMID:11470996 PMID:17550934 |
RGD:5135038 RGD:5135039 |
NCBI chrNW_004936704:1,233,909...1,236,864
Ensembl chrNW_004936704:1,233,780...1,237,329
|
|
G |
Gsto2 |
glutathione S-transferase omega 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:p. N142D (human) |
RGD |
PMID:20374258 |
RGD:5490988 |
NCBI chrNW_004936600:1,907,396...1,925,256
Ensembl chrNW_004936600:1,907,517...1,925,235
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility severity disease_progression no_association |
ISO |
DNA:SNPs:intron,exon:(rs749174), (rs1138272)(human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon:p.I105V (rs1695) (human) DNA:SNPs: :p.I105V, p.A114V (human) DNA:SNP: :p.A114V (human) DNA:SNPs:exons:p.I105V (rs1695), A114V (rs1138272) (human) DNA:polymorphism:exon:p.I105V (human) |
RGD CTD |
PMID:10806136 PMID:11994713 PMID:15693909 PMID:16176403 PMID:16870661 PMID:18057098 PMID:18709160 PMID:18787219 PMID:18988661 PMID:20210814 PMID:20858151 PMID:24117884 PMID:29411558 More...
|
RGD:4140946 RGD:4140947 RGD:4140951 RGD:4142519 RGD:4142526 RGD:5490985 RGD:5490991 RGD:5490999 |
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
|
RGD |
PMID:20628202 |
RGD:5128851 |
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
ISO |
|
RGD |
PMID:17517968 |
RGD:5135525 |
NCBI chrNW_004936515:6,001,324...6,015,407
|
|
G |
Hdac2 |
histone deacetylase 2 |
|
ISO |
mRNA:decreased expression:macrophage: |
RGD |
PMID:20538962 |
RGD:9590321 |
NCBI chrNW_004936679:2,448,676...2,474,641
Ensembl chrNW_004936679:2,448,390...2,474,641
|
|
G |
Hdc |
histidine decarboxylase |
|
ISO |
associated with Rhinitis;DNA:SNP: :p.E644D (rs2073440) (human) |
RGD |
PMID:20608921 |
RGD:5128884 |
NCBI chrNW_004936471:12,303,802...12,324,613
Ensembl chrNW_004936471:12,304,130...12,324,570
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:18160846 |
RGD:10402541 |
NCBI chrNW_004936495:5,770,988...5,816,157
Ensembl chrNW_004936495:5,770,669...5,816,157
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:20084838 |
RGD:5508450 |
NCBI chrNW_004936549:1,378,536...1,400,501
Ensembl chrNW_004936549:1,378,736...1,400,532
|
|
G |
Hmox1 |
heme oxygenase 1 |
severity |
ISO |
mRNA;protein:increased expression:Leukocytes, Mononuclear CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16196283 PMID:18048809 PMID:20596599 |
RGD:4145403 RGD:4145408 |
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
|
|
G |
Hnmt |
histamine N-methyltransferase |
no_association susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD OMIM ClinVar |
PMID:10752634 PMID:10803682 PMID:15693910 PMID:16205835 PMID:17651147 PMID:25741868 More...
|
RGD:5128885 RGD:5128887 RGD:5128888 |
NCBI chrNW_004936469:38,125,877...38,166,429
Ensembl chrNW_004936469:38,122,454...38,166,398
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11932298 |
|
NCBI chrNW_004936475:17,882,663...17,888,708
Ensembl chrNW_004936475:17,882,575...17,887,748
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322896 |
|
NCBI chrNW_004936565:335,238...394,683
Ensembl chrNW_004936565:334,393...394,715
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
mRNA:increased expression:aorta (mouse) protein:increased expression:lung, serum (rat) CTD Direct Evidence: marker/mechanism protein:increased secretion:lung (human) |
RGD CTD |
PMID:17014439 PMID:20205697 PMID:20400685 PMID:20953388 PMID:25003170 |
RGD:4145331 RGD:4145444 RGD:4145509 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Ifng |
interferon gamma |
treatment resistance |
ISO |
protein:increased expression:sputum |
RGD |
PMID:12396623 PMID:19542437 PMID:20817868 PMID:20953328 |
RGD:10755706 RGD:4145525 RGD:4145651 RGD:5128479 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 PMID:21737883 |
RGD:6480255 RGD:6480431 |
NCBI chrNW_004936560:4,519,858...4,545,763
Ensembl chrNW_004936560:4,519,474...4,545,796
|
|
G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25256354 |
|
NCBI chrNW_004936490:14,939,693...15,025,728
Ensembl chrNW_004936490:14,939,776...15,025,728
|
|
G |
Il10 |
interleukin 10 |
treatment susceptibility |
ISO |
protein:decreased expression:plasma CTD Direct Evidence: marker/mechanism DNA:polymorphism: :-627C>A (human) |
RGD CTD |
PMID:12938145 PMID:20121766 PMID:20230687 PMID:20237464 PMID:20560982 PMID:20644177 PMID:21998459 PMID:29317916 More...
|
RGD:11046261 RGD:4140421 RGD:4140451 RGD:4140459 RGD:4140471 RGD:4143221 RGD:5131623 |
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il12a |
interleukin 12A |
|
ISO |
|
RGD |
PMID:17056578 PMID:17548618 |
RGD:4373570 RGD:4438438 |
NCBI chrNW_004936519:6,166,060...6,180,652
Ensembl chrNW_004936519:6,175,261...6,180,396
|
|
G |
Il12b |
interleukin 12B |
severity susceptibility |
ISO |
DNA:polymorphisms:introns: ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphism:promoter DNA:polymorphisms:promoter, 3'utr: |
RGD ClinVar |
PMID:12241719 PMID:15322986 PMID:16210052 |
RGD:1600043 RGD:4145428 RGD:4145438 |
NCBI chrNW_004936515:4,056,214...4,066,121
Ensembl chrNW_004936515:4,056,214...4,065,076
|
|
G |
Il13 |
interleukin 13 |
susceptibility no_association severity |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to DNA:polymorphism:cds:p.R130Q (human) DNA:polymorphism: :c.-1055C>T (human) protein:increased expression:sputum protein:increased expression:serum |
OMIM ClinVar RGD |
PMID:10699178 PMID:11588017 PMID:11678850 PMID:11709756 PMID:11758895 PMID:12847555 PMID:12928861 PMID:15356556 PMID:15483090 PMID:15711639 PMID:15879126 PMID:18258919 PMID:18328894 PMID:20198887 More...
|
RGD:4145593 RGD:4145639 RGD:4145777 RGD:4763153 RGD:4763761 |
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
no_association |
ISO |
DNA:polymorphism: :1050C>T (human) DNA:polymorphisms:promoter, 3' utr:-281T>G, 1365A>G (human) mRNA:increased expression:bronchus DNA:polymorphism: :1398A>G (human) |
RGD |
PMID:10686479 PMID:11714828 PMID:17006604 PMID:17392323 PMID:18480254 PMID:20383033 More...
|
RGD:4892639 RGD:4892646 RGD:4892647 RGD:4892650 RGD:4892654 RGD:4892655 |
NCBI chrNW_004936479:11,052,077...11,108,915
Ensembl chrNW_004936479:11,050,249...11,108,909
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
mRNA:increased expression:bronchus protein:increased expression:serum |
RGD |
PMID:17885690 PMID:20383033 PMID:21462799 |
RGD:4892646 RGD:4892649 RGD:8549521 |
NCBI chrNW_004936499:860,179...883,884
Ensembl chrNW_004936499:863,599...883,855
|
|
G |
Il15 |
interleukin 15 |
no_association |
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:11160248 PMID:15131572 PMID:15843549 PMID:16629787 PMID:19133918 |
RGD:4984421 RGD:4990462 RGD:5000757 RGD:5000758 RGD:5000760 |
NCBI chrNW_004936535:6,344,348...6,358,803
Ensembl chrNW_004936535:6,344,395...6,350,197
|
|
G |
Il16 |
interleukin 16 |
no_association severity |
ISO |
DNA:SNP:promoter:-295T>C (human) protein:increased expression:serum associated with Rhinitis;protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:10585533 PMID:12872394 PMID:15784111 PMID:16387589 PMID:16734115 |
RGD:5024928 RGD:5024930 RGD:5024934 RGD:5024935 RGD:5024937 |
NCBI chrNW_004936483:19,417,580...19,512,654
Ensembl chrNW_004936483:19,418,086...19,512,639
|
|
G |
Il17a |
interleukin 17A |
susceptibility |
ISO |
protein:increased expression:alveolar macrophage DNA:SNP:promoter:rs2275913 (human) protein:increased expression:sputum mRNA,protein:increased expression:Leukocytes, Mononuclear, lung, serum |
RGD |
PMID:15730730 PMID:18060619 PMID:18941201 PMID:20351038 PMID:20437253 |
RGD:4839043 RGD:4888527 RGD:4889114 RGD:4889139 RGD:4889152 |
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il17rb |
interleukin 17 receptor B |
|
ISO |
associated with Picornaviridae Infections |
RGD |
PMID:25273095 |
RGD:39128256 |
NCBI chrNW_004936473:4,512,461...4,524,452
Ensembl chrNW_004936473:4,512,510...4,524,236
|
|
G |
Il18 |
interleukin 18 |
severity susceptibility disease_progression |
ISO |
DNA:SNP:promoter: c.-380C>G (rs5744247)(human) DNA:polymorphism: :c. -105A>C (human) protein:increased expression:serum DNA:SNPs:Promoter:c. -607C>A (rs1946518), -137G/C (rs187238) (human) DNA:SNP:promoter:c.and -137G>C (rs187238)(human) |
RGD |
PMID:11174201 PMID:16433859 PMID:17767553 PMID:18200581 PMID:18826499 PMID:19745201 PMID:20497957 More...
|
RGD:4889585 RGD:4889863 RGD:4889898 RGD:4889900 RGD:4889908 RGD:4889910 RGD:4889923 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
DNA:SNPs: :multiple (human) DNA:SNP: :rs3771166 (human) |
RGD |
PMID:11972614 PMID:18382474 PMID:18774397 PMID:19910030 PMID:20860503 |
RGD:5024942 RGD:5024945 RGD:5024946 RGD:5024947 RGD:5024948 |
NCBI chrNW_004936713:1,038,985...1,075,770
Ensembl chrNW_004936713:1,038,877...1,075,811
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
protein:increased expression:serum mRNA, protein:increased expression:lung, serum |
RGD |
PMID:15557163 |
RGD:5037236 |
NCBI chrNW_004936557:5,765,093...5,769,853
Ensembl chrNW_004936557:5,765,093...5,769,853
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
DNA:polymorphisms: : |
RGD |
PMID:18763028 |
RGD:4142802 |
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
susceptibility |
ISO |
DNA:polymorphism: :-511C>T (human) CTD Direct Evidence: marker/mechanism protein:decreased expression:neutrophil |
RGD CTD |
PMID:9176529 PMID:18926055 PMID:19684087 PMID:19842845 |
RGD:4142830 RGD:4142836 RGD:4142864 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il1rl1 |
interleukin 1 receptor like 1 |
susceptibility severity |
ISO |
protein:increased expression:serum DNA:SNP: :rs1420101 (human) DNA:SNP: :rs10197862 (human) DNA:SNP: :rs1041973 (human) CTD Direct Evidence: marker/mechanism DNA:SNPs:intron:rs1420089, rs1861245,rs1946131 (human) |
RGD CTD |
PMID:11463601 PMID:17407196 PMID:17623648 PMID:19179489 PMID:19198610 PMID:19852851 PMID:21150878 PMID:21281963 PMID:21804549 PMID:24241537 PMID:27472835 More...
|
RGD:5144235 RGD:5144237 RGD:5144239 RGD:5144240 RGD:5144242 RGD:5144243 RGD:5144244 RGD:5144245 |
NCBI chrNW_004936713:1,020,969...1,035,012
Ensembl chrNW_004936713:1,021,044...1,035,039
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility severity |
ISO |
DNA:SNPs: :rs447713, rs3087271 (human) DNA:SNP: :rs2234678 (human) DNA:polymorphism:intron (human) protein:increased expression:plasma CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple (human) DNA, protein:repeat, decreased expression (human) |
RGD CTD |
PMID:9176529 PMID:10843772 PMID:11027520 PMID:15020290 PMID:16409203 PMID:16724092 PMID:17107994 PMID:18763028 PMID:18926055 More...
|
RGD:4142802 RGD:4142864 RGD:4143163 RGD:4143208 RGD:4143209 RGD:4143216 RGD:4143224 RGD:4143225 |
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
|
|
G |
Il2 |
interleukin 2 |
susceptibility |
ISO |
DNA:SNP:promoter:rs2069762(human) |
RGD |
PMID:16333313 PMID:20926789 |
RGD:4889118 RGD:8663473 |
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
|
|
G |
Il21 |
interleukin 21 |
|
ISO |
DNA:SNP:exon:5250C>T (human) |
RGD |
PMID:18802358 |
RGD:5147396 |
NCBI chrNW_004936662:1,689,879...1,696,883
Ensembl chrNW_004936662:1,689,879...1,696,883
|
|
G |
Il22 |
interleukin 22 |
treatment severity |
ISO |
protein:increased expression:serum mRNA:increased expression:blood, mononuclear cell |
RGD |
PMID:21297073 PMID:21535180 PMID:21998459 |
RGD:11046261 RGD:5147403 RGD:5147409 |
NCBI chrNW_004936545:6,227,118...6,231,745
Ensembl chrNW_004936545:6,227,118...6,231,745
|
|
G |
Il23r |
interleukin 23 receptor |
|
ISO |
|
RGD |
PMID:19935773 |
RGD:5037240 |
NCBI chrNW_004936591:4,365,598...4,425,053
Ensembl chrNW_004936591:4,365,762...4,425,005
|
|
G |
Il25 |
interleukin 25 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:25273095 |
RGD:39128256 |
NCBI chrNW_004936722:997,476...1,000,881
Ensembl chrNW_004936722:996,960...1,003,201
|
|
G |
Il27 |
interleukin 27 |
treatment susceptibility |
ISO |
DNA:SNP: :g.-964A>G (human) protein:increased expression:sputum |
RGD |
PMID:17318299 PMID:17878337 PMID:19542437 PMID:20817868 PMID:26595888 |
RGD:11076728 RGD:4145651 RGD:5128479 RGD:5128485 RGD:5128491 |
NCBI chrNW_004936501:11,972,715...11,978,152
Ensembl chrNW_004936501:11,973,385...11,976,583
|
|
G |
Il27ra |
interleukin 27 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:16081811 |
RGD:5128496 |
NCBI chrNW_004936659:2,706,037...2,720,486
Ensembl chrNW_004936659:2,705,985...2,722,748
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17351063 PMID:20525707 PMID:21377197 |
RGD:2325990 RGD:5147437 RGD:5147445 |
NCBI chrNW_004936484:8,514,333...8,555,392
Ensembl chrNW_004936484:8,544,062...8,555,332
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
|
ISO |
DNA:SNP: :rs2284033 (human) |
RGD |
PMID:18641329 PMID:20860503 |
RGD:5024942 RGD:5147447 |
NCBI chrNW_004936492:3,795,940...3,805,822
Ensembl chrNW_004936492:3,795,940...3,805,774
|
|
G |
Il3 |
interleukin 3 |
susceptibility |
ISO |
DNA:SNP: :rs40401(human) DNA:polymorphism:cds:+79T>C(S27P)(human) |
RGD |
PMID:15372320 PMID:24684517 |
RGD:13506914 RGD:13506916 |
NCBI chrNW_004936647:3,102,922...3,104,758
|
|
G |
Il33 |
interleukin 33 |
treatment severity |
ISO |
CTD Direct Evidence: marker/mechanism associated with viral pneumonia; associated with fungal infectious disease |
CTD RGD |
PMID:19198610 PMID:21804549 PMID:24241537 PMID:25746970 PMID:27472835 PMID:28947081 PMID:29067999 More...
|
RGD:39938968 RGD:39939002 |
NCBI chrNW_004936539:763,755...791,461
Ensembl chrNW_004936539:623,248...791,470
|
|
G |
Il4r |
interleukin 4 receptor |
susceptibility disease_progression severity |
ISO |
DNA:polymorphism::-1902G/A (human) OMIM:600807 DNA:polymorphism:cds:p. S478P (human) DNA:SNPs:cds:p. I75V, Q576R (human) DNA:SNPs:cds:p.E375A, Q551R (human) DNA:polymorphism:cds:p.Q551R (human) DNA:polymorphism:cds:p.I50V (human) DNA:SNPs: :multiple DNA:polymorphism:cds:p.Q576R (human) protein:increased secretion:plasma DNA:mutation:cds:p.Q576R (mouse) |
RGD MouseDO |
PMID:11398072 PMID:11709756 PMID:12133990 PMID:12940513 PMID:15479272 PMID:16917945 PMID:17170387 PMID:17586032 PMID:17823973 PMID:18425216 PMID:19770271 PMID:20605987 PMID:20868478 PMID:20953944 More...
|
RGD:4890003 RGD:4890024 RGD:4890346 RGD:4890347 RGD:4890348 RGD:4890349 RGD:4890351 RGD:4890352 RGD:4890387 RGD:4890402 RGD:4890404 RGD:4890406 RGD:5128514 RGD:5128553 |
NCBI chrNW_004936501:11,025,590...11,058,807
Ensembl chrNW_004936501:11,025,567...11,058,818
|
|
G |
Il5 |
interleukin 5 |
treatment disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-703C>T (human) protein: increased levels: sputum protein:increased expression:lungs, respiratory system fluid/secretion protein:increased expression:respiratory system fluid/secretion |
CTD RGD |
PMID:7540862 PMID:9182686 PMID:9493449 PMID:11159041 PMID:15502111 PMID:15626484 PMID:17074272 PMID:18629290 PMID:19947994 PMID:22085848 PMID:22186238 PMID:23266719 PMID:25008888 More...
|
RGD:11354973 RGD:4145461 RGD:4890938 RGD:4890940 RGD:4890947 RGD:4890948 RGD:4890962 RGD:4890963 RGD:5687140 RGD:5687144 RGD:5687189 |
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
|
|
G |
Il5ra |
interleukin 5 receptor subunit alpha |
|
ISO |
DNA:SNP: :c.25091G>A (human) DNA:SNPs (human) |
RGD |
PMID:10224351 PMID:10848907 PMID:16217591 PMID:17276963 PMID:20513521 PMID:20592918 More...
|
RGD:5128614 RGD:5128617 RGD:5128623 RGD:5128625 RGD:5128626 RGD:5128627 |
NCBI chrNW_004936577:2,776,608...2,797,303
Ensembl chrNW_004936577:2,776,721...2,797,300
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
associated with Hypersensitivity;protein:increased expression:sputum protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20658762 PMID:20816188 PMID:20840469 PMID:21115736 PMID:29902480 |
RGD:4143265 RGD:4143266 RGD:4143271 RGD:5128630 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17496315 PMID:21115736 PMID:29902480 |
RGD:5128630 RGD:5128662 |
NCBI chrNW_004936580:4,055,438...4,081,876
Ensembl chrNW_004936580:4,057,771...4,081,885
|
|
G |
Il9 |
interleukin 9 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion protein:increased expression:sputum, macrophage, cytoplasm |
RGD |
PMID:12153980 PMID:15303135 PMID:15531759 PMID:17446528 PMID:21356110 |
RGD:5128686 RGD:5128690 RGD:5128691 RGD:5128700 RGD:5128707 |
NCBI chrNW_004936597:2,983,953...2,986,975
Ensembl chrNW_004936597:2,983,953...2,986,975
|
|
G |
Il9r |
interleukin 9 receptor |
|
ISO |
|
RGD |
PMID:10629460 |
RGD:5128704 |
NCBI chrNW_004936501:829,236...840,130
Ensembl chrNW_004936501:829,236...840,048
|
|
G |
Irak3 |
interleukin 1 receptor associated kinase 3 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 5 |
OMIM ClinVar |
PMID:17503328 |
|
NCBI chrNW_004936545:4,233,353...4,284,324
Ensembl chrNW_004936545:4,233,358...4,282,806
|
|
G |
Irf1 |
interferon regulatory factor 1 |
susceptibility no_association |
ISO |
protein:increased expression:respiratory tract epithelium DNA:repeat:intron (human) DNA:polymorphisms:promoter, cds:-300G>T, 4396A>G, 6355G>A (human) |
RGD |
PMID:10225979 PMID:11069564 PMID:16961714 |
RGD:5128723 RGD:5128724 RGD:5128726 |
NCBI chrNW_004936647:2,686,247...2,693,633
Ensembl chrNW_004936647:2,686,414...2,693,636
|
|
G |
Irf3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20673978 |
RGD:5128793 |
NCBI chrNW_004936664:3,477,750...3,482,489
Ensembl chrNW_004936664:3,475,543...3,481,533
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
ISO |
DNA:SNPs: : |
RGD |
PMID:17556058 |
RGD:5037230 |
NCBI chrNW_004936541:2,822,789...2,871,069
Ensembl chrNW_004936541:2,815,738...2,871,035
|
|
G |
Itgb6 |
integrin subunit beta 6 |
|
ISO |
OMIM:600807 |
MouseDO |
|
|
NCBI chrNW_004936469:18,581,855...18,650,109
Ensembl chrNW_004936469:18,581,840...18,650,123
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor type 1 |
|
ISO |
|
RGD |
PMID:21777465 |
RGD:5147661 |
NCBI chrNW_004936577:3,896,455...4,198,396
Ensembl chrNW_004936577:3,896,390...4,198,411
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
associated with Rhinitis,Allergic,Seasonal;protein:increased expression:nasal cavity of mucosa: |
RGD |
PMID:17651148 PMID:20921519 |
RGD:5684385 RGD:8551771 |
NCBI chrNW_004936482:17,537,697...17,581,320
Ensembl chrNW_004936482:17,538,864...17,581,002
|
|
G |
Kif3a |
kinesin family member 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004936647:2,461,017...2,502,550
Ensembl chrNW_004936647:2,461,138...2,501,871
|
|
G |
Krt19 |
keratin 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15478392 |
|
NCBI chrNW_004936490:16,440,723...16,444,679
Ensembl chrNW_004936490:16,440,693...16,444,791
|
|
G |
Lep |
leptin |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:19705789 |
RGD:5128781 |
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
|
|
G |
Lgals3 |
galectin 3 |
treatment |
ISO |
|
RGD |
PMID:16424226 |
RGD:9685213 |
NCBI chrNW_004936697:20,861...38,568
Ensembl chrNW_004936697:27,145...38,586
|
|
G |
LOC101955076 |
low affinity immunoglobulin gamma Fc region receptor III-A |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chrNW_004937131:42,523...49,533
|
|
G |
LOC101958908 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:21814517 |
RGD:13506911 |
NCBI chrNW_004936476:25,743,512...25,750,809
Ensembl chrNW_004936476:25,743,456...25,750,907
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
DNA:polymorphism: :1934G>A (human) |
RGD |
PMID:19575027 |
RGD:5143944 |
NCBI chrNW_004936718:153,340...157,966
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
DNA:polymorphisms: : DNA:haplotype CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16792590 PMID:17956852 PMID:21217921 PMID:21814517 |
RGD:13506911 RGD:5143938 |
NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145
|
|
G |
LOC101964209 |
C-C chemokine receptor type 1 |
severity |
ISO |
associated with Respiratory Syncytial Virus Infections mRNA:increased expression:lung |
RGD |
PMID:15593301 PMID:15654816 |
RGD:5688158 RGD:5688159 |
NCBI chrNW_004936596:177,774...183,186
Ensembl chrNW_004936596:177,812...183,186
|
|
G |
LOC101967032 |
cytochrome b-245 light chain |
susceptibility |
ISO |
DNA:polymorphism: :-930A>G (human) DNA:SNPs: :-930A>G, 242C>T, 640A>G (human) |
RGD |
PMID:18716406 PMID:19459419 |
RGD:4311041 RGD:4772770 |
NCBI chrNW_004936641:1,036,967...1,044,954
Ensembl chrNW_004936641:1,036,967...1,044,991
|
|
G |
LOC101968486 |
HLA class II histocompatibility antigen, DQ alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: :rs3916765(human) |
RGD |
PMID:20159242 |
RGD:13506913 |
NCBI chrNW_004936727:373,464...378,784
|
|
G |
LOC101968920 |
eotaxin |
severity susceptibility treatment |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:lung protein:increased expression:plasma |
RGD CTD OMIM |
PMID:9034156 PMID:16304252 PMID:17060636 PMID:17074272 PMID:18250471 PMID:20704746 PMID:22932891 More...
|
RGD:4145387 RGD:4145392 RGD:4145451 RGD:4145461 RGD:4891485 RGD:5130930 RGD:7248416 |
NCBI chrNW_004936538:835,436...848,907
Ensembl chrNW_004936538:835,859...837,710 Ensembl chrNW_004936538:835,859...837,710
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:19383228 PMID:19484664 |
RGD:4140913 RGD:4140919 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
LOC101969065 |
mamu class II histocompatibility antigen, DR alpha chain |
susceptibility |
ISO |
DNA:polymorphisms: : |
RGD |
PMID:20159242 |
RGD:13506913 |
NCBI chrNW_004936727:540,225...544,968
Ensembl chrNW_004936727:540,217...545,036
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
|
ISO |
mRNA, protein:increased expression, decreased activity:lung |
RGD |
PMID:12415424 |
RGD:4892074 |
NCBI chrNW_004936471:33,682,730...33,688,332
Ensembl chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:leukocyte |
CTD RGD |
PMID:17081494 PMID:20514434 PMID:28807506 |
RGD:4892076 RGD:4892220 |
NCBI chrNW_004936486:19,691,822...19,702,684
Ensembl chrNW_004936486:19,691,822...19,702,102
|
|
G |
LOC101976500 |
haptoglobin |
|
ISO |
|
RGD |
PMID:21169467 PMID:21471098 |
RGD:5144151 RGD:5509920 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Lta |
lymphotoxin alpha |
susceptibility no_association |
ISO |
DNA:polymorphism:intron DNA:polymorphisms:promoter |
RGD |
PMID:12530118 PMID:15969671 PMID:17536219 PMID:18947013 |
RGD:4143254 RGD:4143370 RGD:4143371 RGD:4143373 |
NCBI chrNW_004936727:1,940,081...1,941,022
Ensembl chrNW_004936727:1,940,081...1,941,022
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
|
ISO |
mRNA:increased expression:lung, cerebral cortex (rat) |
RGD |
PMID:15715933 |
RGD:2316607 |
NCBI chrNW_004936507:12,082,373...12,120,078
Ensembl chrNW_004936507:12,082,068...12,120,091
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
susceptibility |
ISO |
DNA:mutations:exons |
RGD |
PMID:18219832 |
RGD:5129186 |
NCBI chrNW_004936694:970,706...980,605
|
|
G |
Mif |
macrophage migration inhibitory factor |
severity |
ISO |
DNA:repeats:promoter DNA:SNP:promoter:rs755622(human) protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:9637721 PMID:16186482 PMID:16455830 PMID:17373669 PMID:19317738 |
RGD:1641985 RGD:4891035 RGD:4891043 RGD:4891052 RGD:4891059 |
NCBI chrNW_004936619:1,207,058...1,208,010
Ensembl chrNW_004936619:1,203,746...1,208,442
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24469321 |
|
NCBI chrNW_004936551:5,167,909...5,175,149
Ensembl chrNW_004936551:5,168,044...5,174,857
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16926187 |
|
NCBI chrNW_004936551:5,188,395...5,197,477
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:lung CTD Direct Evidence: marker/mechanism DNA:SNP: : rs2664538(human) mRNA, protein:increased expression:lung protein:increased expression:serum |
RGD CTD |
PMID:11742282 PMID:15131573 PMID:16191269 PMID:19361849 PMID:19940022 PMID:20181264 PMID:21439806 More...
|
RGD:2325953 RGD:5129204 RGD:5129522 RGD:5129687 RGD:5130859 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Mpo |
myeloperoxidase |
susceptibility |
ISO |
DNA:polymorphism: :−463G > A (human) protein:increased expression:serum |
RGD |
PMID:10731862 PMID:19544176 |
RGD:5130989 RGD:5130994 |
NCBI chrNW_004936490:4,809,773...4,819,070
Ensembl chrNW_004936490:4,809,631...4,819,070
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
susceptibility |
ISO |
Atopy and bronchial hyperresponsiveness, OMIM:147050 DNA:polymorphism:CDS:amino acid E237G DNA:SNPs: : rs556917, rs502581, rs502419 (human) DNA:SNPs:multiple:, rs573790, rs2583476, rs569108 DNA:SNP: : -109C>T (human) |
RGD |
PMID:8817330 PMID:19218813 PMID:19862939 PMID:21320344 |
RGD:1599903 RGD:5131092 RGD:5131149 RGD:5131151 |
NCBI chrNW_004936581:2,743,133...2,751,925
Ensembl chrNW_004936581:2,744,881...2,751,925
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
DNA:transition:cds:g.677C>T (human) |
RGD |
PMID:20456312 |
RGD:4891145 |
NCBI chrNW_004936474:623,438...637,849
Ensembl chrNW_004936474:623,291...638,193
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:11802251 |
RGD:5131281 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
associated with hypersensitivity |
RGD |
PMID:11062147 PMID:14594655 |
RGD:5131178 RGD:7349354 |
NCBI chrNW_004936816:60,499...91,628
Ensembl chrNW_004936816:60,499...91,628
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
treatment |
ISO |
mRNA, protein:increased expression:lung mRNA,protein:increased expression:lung |
RGD |
PMID:14594655 PMID:17590487 PMID:17698377 PMID:21549818 PMID:21780541 |
RGD:2324962 RGD:5131204 RGD:7349354 RGD:7349407 RGD:7364729 |
NCBI chrNW_004936816:129,926...159,396
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
protein:altered expression:sputum |
RGD |
PMID:11587997 PMID:11802783 |
RGD:5131252 RGD:7364763 |
NCBI chrNW_004936816:174,943...209,241
|
|
G |
Muc7 |
mucin 7, secreted |
|
ISO |
ClinVar Annotator: match by term: Asthma, protection against |
ClinVar OMIM |
PMID:11378823 PMID:16759176 PMID:28492532 |
|
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19198610 |
|
NCBI chrNW_004936560:2,797,943...2,828,813
Ensembl chrNW_004936560:2,796,697...2,829,650
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
ameliorates |
ISO |
|
RGD |
PMID:26882889 |
RGD:11531666 |
NCBI chrNW_004936473:27,672,237...27,676,339
Ensembl chrNW_004936473:27,671,797...27,676,372
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
|
RGD |
PMID:17472811 |
RGD:4891492 |
NCBI chrNW_004936725:1,418,930...1,594,697
Ensembl chrNW_004936725:1,424,130...1,592,840
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
severity |
ISO |
mRNA:increased expression:bronchoalveolar lavage cell, peripheral blood mononuclear cell (human) |
RGD |
PMID:21514635 |
RGD:6893376 |
NCBI chrNW_004936509:6,589,967...6,621,171
Ensembl chrNW_004936509:6,590,630...6,620,262
|
|
G |
Ngf |
nerve growth factor |
severity |
ISO |
protein:increased expression:blood, eosinophil protein:increased expression:lung, serum |
RGD |
PMID:11737043 PMID:12752594 PMID:17164945 PMID:17497413 |
RGD:4891068 RGD:4891108 RGD:4891122 RGD:4891123 |
NCBI chrNW_004936627:635,784...641,290
Ensembl chrNW_004936627:635,788...645,364
|
|
G |
Ngfr |
nerve growth factor receptor |
|
ISO |
|
RGD |
PMID:12540484 PMID:16603479 |
RGD:5144070 RGD:5144072 |
NCBI chrNW_004936490:12,038,500...12,057,257
Ensembl chrNW_004936490:12,035,769...12,057,263
|
|
G |
Nod1 |
nucleotide binding oligomerization domain containing 1 |
susceptibility |
ISO |
DNA:SNP: :rs2075817 (human) DNA:insertion:cds: |
RGD |
PMID:15718249 PMID:16918516 |
RGD:5131518 RGD:5131519 |
NCBI chrNW_004936478:6,717,354...6,768,293
Ensembl chrNW_004936478:6,715,245...6,768,372
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
susceptibility |
ISO |
DNA:polymorphisms:intron, exon/3'UTR (rs1077861, rs3135500) (human) |
RGD |
PMID:16008671 PMID:21051079 |
RGD:5131477 RGD:5508757 |
NCBI chrNW_004936475:3,708,069...3,742,845
Ensembl chrNW_004936475:3,713,362...3,745,982
|
|
G |
Nos1 |
nitric oxide synthase 1 |
susceptibility |
ISO |
DNA:repeats:exon DNA:repeats:intron DNA:repeats: : |
RGD |
PMID:10673365 PMID:10833424 PMID:14767694 PMID:20609134 |
RGD:5132615 RGD:5132860 RGD:5132863 RGD:5132869 |
NCBI chrNW_004936558:5,162,471...5,302,488
Ensembl chrNW_004936558:5,233,459...5,301,414
|
|
G |
Nos2 |
nitric oxide synthase 2 |
severity no_association disease_progression |
ISO |
associated with Rhinitis, Allergic, Seasonal; protein:increased expression:nasal mucosa DNA:SNP:exon:p.S608L (human) DNA:repeat:promoter protein:increased expression:lung, bronchoalveolar lavage fluid DNA:repeats:promoter protein:increased expression, increased activity:lung (rat) CTD Direct Evidence: marker/mechanism DNA:repeats:promoter, introns (human) mRNA:increased expression:monocyte |
RGD CTD |
PMID:16540403 PMID:16703578 PMID:17161822 PMID:17177683 PMID:17189532 PMID:18254476 PMID:18714530 PMID:19800904 PMID:20841959 PMID:20842520 PMID:21847581 More...
|
RGD:4891419 RGD:4891480 RGD:4891508 RGD:4891910 RGD:4891924 RGD:4891925 RGD:4891927 RGD:4891953 RGD:4891957 RGD:5509073 |
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
|
|
G |
Nos3 |
nitric oxide synthase 3 |
susceptibility |
ISO |
DNA:repeats:intron DNA:polymorphisms:promoter:c. -786C>T, -691C>T (human) DNA:snps, repeat, haplotype:promoter, introns, exons:multiple (human) |
RGD |
PMID:16081038 PMID:16837812 PMID:18486767 |
RGD:4892053 RGD:4892058 RGD:4892062 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Asthma-related traits, susceptibility to, 2 |
OMIM ClinVar |
PMID:15073379 |
|
NCBI chrNW_004936478:10,352,894...10,542,949
Ensembl chrNW_004936478:10,352,741...10,544,102
|
|
G |
Npy |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chrNW_004936478:1,289,437...1,296,819
Ensembl chrNW_004936478:1,290,505...1,296,874
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP:exon:c. 609C>T (human) DNA:SNP:exon:c.609C>T (human) |
CTD RGD |
PMID:19027876 PMID:19591959 PMID:20049212 |
RGD:5135005 RGD:5135006 |
NCBI chrNW_004936475:19,771,384...19,785,034
Ensembl chrNW_004936475:19,769,488...19,785,311
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
severity treatment susceptibility |
ISO |
protein:increased expression, decreased activity:leukocyte, mononuclear DNA:polymorphism:intron |
RGD |
PMID:15295049 PMID:18396779 PMID:18799869 PMID:20727335 PMID:21113676 PMID:28297812 More...
|
RGD:408364991 RGD:4892328 RGD:4892568 RGD:4892594 RGD:4892609 RGD:7174728 |
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
|
|
G |
Ntf3 |
neurotrophin 3 |
|
ISO |
protein:increased expression:lung, serum |
RGD |
PMID:11737043 PMID:17497413 |
RGD:4891068 RGD:4891123 |
NCBI chrNW_004936709:2,163,510...2,223,429
Ensembl chrNW_004936709:2,163,334...2,223,552
|
|
G |
Ntf4 |
neurotrophin 4 |
|
ISO |
protein:increased expression:lung, serum |
RGD |
PMID:17497413 |
RGD:4891068 |
NCBI chrNW_004936664:3,017,108...3,017,955
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:16708804 PMID:20934630 |
RGD:5684766 RGD:5684772 |
NCBI chrNW_004936580:6,002,168...6,021,690
Ensembl chrNW_004936580:6,002,120...6,021,709
|
|
G |
Ormdl3 |
ORMDL sphingolipid biosynthesis regulator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21150878 PMID:25256354 |
|
NCBI chrNW_004936490:15,069,435...15,076,112
Ensembl chrNW_004936490:15,069,387...15,076,253
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
|
ISO |
|
RGD |
PMID:19822647 PMID:22010907 |
RGD:6480532 RGD:6480533 |
NCBI chrNW_004936758:1,581,828...1,624,332
Ensembl chrNW_004936758:1,581,897...1,592,222
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
treatment |
ISO |
protein:increased activation:lung, blood, mononuclear cell CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12594058 PMID:18261157 PMID:26205779 |
RGD:11073727 RGD:5683910 |
NCBI chrNW_004936526:3,102,468...3,147,601
Ensembl chrNW_004936526:3,102,039...3,147,642
|
|
G |
Pdcd1 |
programmed cell death 1 |
treatment |
ISO |
associated with Chlamydia pneumonia |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chrNW_004936745:152,571...163,712
Ensembl chrNW_004936745:152,612...161,587
|
|
G |
Pde4b |
phosphodiesterase 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21912604 |
|
NCBI chrNW_004936591:5,152,491...5,666,728
Ensembl chrNW_004936591:5,152,441...5,573,129
|
|
G |
Pde4d |
phosphodiesterase 4D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19426955 PMID:21611147 |
|
NCBI chrNW_004936480:8,123,437...9,235,586
Ensembl chrNW_004936480:8,204,701...9,234,865
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
protein: increased expression |
RGD |
PMID:21216974 |
RGD:6483071 |
NCBI chrNW_004936492:2,353,840...2,368,573
Ensembl chrNW_004936492:2,353,841...2,368,573
|
|
G |
Pgf |
placental growth factor |
|
ISO |
|
RGD |
PMID:22268141 |
RGD:6483605 |
NCBI chrNW_004936488:4,098,187...4,111,108
Ensembl chrNW_004936488:4,098,225...4,111,142
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:18754810 |
RGD:6482695 |
NCBI chrNW_004936479:17,084,006...17,112,264
Ensembl chrNW_004936479:17,084,920...17,112,258
|
|
G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
ISO |
|
RGD |
PMID:18188456 |
RGD:8693422 |
NCBI chrNW_004936659:309,530...321,294
Ensembl chrNW_004936659:309,506...321,334
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
|
RGD |
PMID:15557087 |
RGD:1642462 |
NCBI chrNW_004936481:3,559,377...3,689,797
Ensembl chrNW_004936481:3,559,358...3,689,833
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10733466 |
RGD:1581025 |
NCBI chrNW_004936476:13,609,847...13,646,174
Ensembl chrNW_004936476:13,609,374...13,649,998
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18519237 PMID:21912604 |
RGD:4892037 |
NCBI chrNW_004936521:5,238,128...5,243,829
Ensembl chrNW_004936521:5,238,093...5,243,877
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22205926 |
|
NCBI chrNW_004936647:1,031,118...1,055,961
Ensembl chrNW_004936647:1,031,119...1,055,149
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:21426642 PMID:22250087 |
RGD:6482815 RGD:6482818 |
NCBI chrNW_004936521:8,057,874...8,060,695
Ensembl chrNW_004936521:8,057,874...8,060,695
|
|
G |
Prg2 |
proteoglycan 2, pro eosinophil major basic protein |
severity disease_progression no_association |
ISO |
mRNA:increased expression:eosinophil: associated with viral infection;mRNA:increased expression:sputum: associated with cough;protein:increased expression:sputum: |
RGD |
PMID:11067904 PMID:16982448 PMID:22022864 PMID:24450586 |
RGD:13506941 RGD:13506942 RGD:13506943 RGD:13506944 |
NCBI chrNW_004936581:5,101,041...5,103,175
Ensembl chrNW_004936581:5,100,623...5,102,857
|
|
G |
Prmt1 |
protein arginine methyltransferase 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004936664:3,492,032...3,502,738
Ensembl chrNW_004936664:3,491,920...3,504,667
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
|
ISO |
mRNA:increased expression:lung, spleen |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004936778:12,988...31,217
Ensembl chrNW_004936778:12,967...29,077
|
|
G |
Prmt3 |
protein arginine methyltransferase 3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004936654:1,336,546...1,464,959
Ensembl chrNW_004936654:1,336,429...1,461,476
|
|
G |
Prmt5 |
protein arginine methyltransferase 5 |
|
ISO |
mRNA:increased expression:lung, spleen |
RGD |
PMID:20423833 |
RGD:9491823 |
NCBI chrNW_004936722:1,379,515...1,388,538
Ensembl chrNW_004936722:1,379,515...1,388,546
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:26381519 |
RGD:11099992 |
NCBI chrNW_004936469:43,841,989...43,850,322
Ensembl chrNW_004936469:43,841,989...43,850,304
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17982072 |
|
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Ptgdr |
prostaglandin D2 receptor |
susceptibility |
ISO |
|
OMIM |
|
|
NCBI chrNW_004936697:2,481,340...2,488,868
Ensembl chrNW_004936697:2,481,340...2,488,868
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: therapeutic Aspirin exacerbated asthma |
RGD CTD |
PMID:18757520 PMID:19392992 PMID:19796209 PMID:27103662 |
RGD:5135018 RGD:5135019 RGD:5135020 |
NCBI chrNW_004936581:2,069,355...2,072,535
Ensembl chrNW_004936581:2,067,546...2,070,893
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
treatment |
ISO |
|
RGD |
PMID:23221044 |
RGD:10043366 |
NCBI chrNW_004936591:1,174,364...1,250,233
Ensembl chrNW_004936591:1,174,069...1,249,410
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
susceptibility severity |
ISO |
DNA:SNP: :8473T>C (human) mRNA:increased expression:lung DNA:SNP: :rs689465 (human) mRNA, protein:increased expression:lung: |
RGD |
PMID:15316498 PMID:17573729 PMID:18097056 PMID:18489027 PMID:19342146 PMID:19862936 PMID:19878559 More...
|
RGD:5135514 RGD:5135515 RGD:5135522 RGD:5135526 RGD:5135534 RGD:5143923 RGD:5143931 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24241537 |
|
NCBI chrNW_004936647:2,546,100...2,637,524
Ensembl chrNW_004936647:2,543,599...2,637,846
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
|
RGD |
PMID:18391481 |
RGD:2298885 |
NCBI chrNW_004936529:1,000,050...1,045,655
Ensembl chrNW_004936529:999,935...1,045,681
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
DNA:SNPs: :multiple |
RGD |
PMID:21803869 |
RGD:6482835 |
NCBI chrNW_004936500:7,621,328...7,710,909
Ensembl chrNW_004936500:7,486,954...7,709,504
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
OMIM:600807 |
MouseDO |
|
|
NCBI chrNW_004936474:9,751,946...9,802,910
Ensembl chrNW_004936474:9,751,946...9,802,910
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
susceptibility |
ISO |
associated with allergic rhinitis; DNA:SNP:exon:38G>A (human) ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD ClinVar |
PMID:9550363 PMID:9643286 PMID:12100044 PMID:21255142 |
RGD:5144226 |
NCBI chrNW_004936581:798,738...801,614
Ensembl chrNW_004936581:798,739...801,633
|
|
G |
Scgb3a2 |
secretoglobin family 3A member 2 |
susceptibility severity no_association |
ISO |
ClinVar Annotator: match by term: Asthma, susceptibility to DNA:SNP:promoter:-112G>A (human) |
OMIM ClinVar RGD |
PMID:11813133 PMID:18089940 PMID:18201431 |
RGD:5144230 RGD:5144231 |
NCBI chrNW_004936504:6,933,641...6,936,838
Ensembl chrNW_004936504:6,933,769...6,936,838
|
|
G |
Sell |
selectin L |
|
ISO |
|
RGD |
PMID:21437035 PMID:21515793 |
RGD:5685685 RGD:5685696 |
NCBI chrNW_004936481:17,022,421...17,032,105
Ensembl chrNW_004936481:17,022,580...17,032,124
|
|
G |
Serpine1 |
serpin family E member 1 |
susceptibility severity no_association |
ISO |
DNA:polymorphism:promoter:rs1799768 (human) protein:increased expression:plasma protein:increased activity, increased expression:plasma, lung |
RGD |
PMID:18594148 PMID:19063817 PMID:19604112 PMID:19703828 |
RGD:4144831 RGD:4144832 RGD:4144833 RGD:4144836 |
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
|
|
G |
Sftpb |
surfactant protein B |
|
ISO |
protein:increased expression:lung protein:decreased expression:lung, Clara cell mRNA, protein:decreased expression:lung |
RGD |
PMID:11472974 PMID:15816355 PMID:16629790 PMID:18926058 |
RGD:4143289 RGD:4143398 RGD:4143462 RGD:4143465 |
NCBI chrNW_004936712:1,614,979...1,621,207
Ensembl chrNW_004936712:1,614,979...1,622,466
|
|
G |
Sftpc |
surfactant protein C |
susceptibility |
ISO |
DNA:polymorphism: :p.A53T (human) mRNA, protein:decreased expression:lung protein:increased expression:lung |
RGD |
PMID:11472974 PMID:16629790 PMID:19910179 |
RGD:4143462 RGD:4143465 RGD:4144063 |
NCBI chrNW_004936555:5,966,610...5,982,083
Ensembl chrNW_004936555:5,979,417...5,982,011
|
|
G |
Sftpd |
surfactant protein D |
|
ISO |
associated with Bronchitis;protein:increased expression:lung mRNA, protein:increased expression:lung |
RGD |
PMID:11472974 PMID:16629790 PMID:16839409 PMID:18266831 PMID:18802356 |
RGD:4143462 RGD:4143465 RGD:4143508 RGD:4143516 RGD:4143517 |
NCBI chrNW_004936716:60,754...73,010
Ensembl chrNW_004936716:60,656...73,099
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
|
ISO |
|
RGD |
PMID:12847242 |
RGD:5684966 |
NCBI chrNW_004936569:888,309...895,991
Ensembl chrNW_004936569:887,742...895,977
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
|
ISO |
|
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004936728:703,688...706,317
Ensembl chrNW_004936728:704,290...705,885
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
ISO |
|
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004936489:11,534,095...11,556,759
Ensembl chrNW_004936489:11,534,095...11,556,745
|
|
G |
Slc5a7 |
solute carrier family 5 member 7 |
|
ISO |
mRNA:decreased expression:lung |
RGD |
PMID:17328924 |
RGD:5686690 |
NCBI chrNW_004936729:1,511,648...1,534,042
Ensembl chrNW_004936729:1,511,836...1,536,200
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
susceptibility |
ISO |
DNA:repeat:intron (human) |
RGD |
PMID:19806585 |
RGD:4889460 |
NCBI chrNW_004936538:6,205,268...6,239,062
Ensembl chrNW_004936538:6,205,251...6,239,083
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22867017 |
|
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
|
RGD |
PMID:15743779 |
RGD:1581231 |
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18211752 PMID:28807506 |
RGD:2317290 |
NCBI chrNW_004936506:7,091,982...7,185,938
Ensembl chrNW_004936506:7,095,009...7,184,689
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
treatment |
ISO |
|
RGD |
PMID:16083555 PMID:19087723 |
RGD:7244151 RGD:7244153 |
NCBI chrNW_004936646:1,297,530...1,312,508
Ensembl chrNW_004936646:1,296,290...1,312,157
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11031342 |
RGD:5147836 |
NCBI chrNW_004936585:2,932,783...2,941,141
Ensembl chrNW_004936585:2,932,727...2,941,384
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
protein:increased expression:lung mRNA:increased expression:lung mRNA,protein:increased expression:lung |
RGD |
PMID:8240667 PMID:16409782 PMID:17392578 |
RGD:2304339 RGD:5147475 RGD:5147645 |
NCBI chrNW_004936556:1,266,621...1,421,271
Ensembl chrNW_004936556:1,266,613...1,421,275
|
|
G |
Tacr2 |
tachykinin receptor 2 |
|
ISO |
DNA:SNP:cds:p.G231E (human) |
RGD |
PMID:19880429 PMID:20175803 |
RGD:5147640 RGD:5147641 |
NCBI chrNW_004936521:9,053,179...9,065,790
Ensembl chrNW_004936521:9,053,179...9,065,797
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
susceptibility |
ISO |
DNA:polymorphism: : |
RGD |
PMID:12640628 |
RGD:5147845 |
NCBI chrNW_004936476:25,899,514...25,907,690
Ensembl chrNW_004936476:25,899,339...25,907,695
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism OMIM:600807 |
CTD MouseDO |
PMID:15806396 |
|
NCBI chrNW_004936490:13,546,405...13,558,635
Ensembl chrNW_004936490:13,546,292...13,558,635
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
severity susceptibility |
ISO |
DNA:polymorphism:cds:924T>C(human) ClinVar Annotator: match by term: Asthma |
RGD ClinVar |
PMID:2955539 PMID:7929844 PMID:8428006 PMID:8613548 PMID:12000493 PMID:15805995 More...
|
RGD:11059534 RGD:11059535 |
NCBI chrNW_004936588:2,040,712...2,044,635
Ensembl chrNW_004936588:2,040,630...2,045,110
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
no_association onset |
ISO |
DNA:polymorphism: :-509C>T (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :multiple (human) DNA:SNP:cds:915G>C (human) mRNA:increased expression:lung protein:increased expression:serum DNA:SNP: :-509C>T (human) DNA:SNPs:promoter, exon:multiple (human) |
RGD CTD |
PMID:16365456 PMID:17673695 PMID:18366906 PMID:18711258 PMID:19046298 PMID:19096005 PMID:19136038 PMID:19138248 PMID:19222424 PMID:19317336 PMID:19533439 PMID:19620629 PMID:20485865 More...
|
RGD:4143443 RGD:4145113 RGD:4145132 RGD:4145139 RGD:4145142 RGD:4145143 RGD:4145144 RGD:4145280 RGD:4145295 RGD:4145297 RGD:4145299 |
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
|
RGD |
PMID:20709825 |
RGD:5684984 |
NCBI chrNW_004936620:2,563,900...2,568,117
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16926187 |
|
NCBI chrNW_004936492:6,996,627...7,046,137
Ensembl chrNW_004936492:6,996,613...7,046,190
|
|
G |
Tlr1 |
toll like receptor 1 |
susceptibility |
ISO |
DNA:SNP (human) |
RGD |
PMID:18547625 |
RGD:4889528 |
NCBI chrNW_004936482:6,582,430...6,591,128
Ensembl chrNW_004936482:6,582,584...6,584,971
|
|
G |
Tlr10 |
toll like receptor 10 |
susceptibility |
ISO |
DNA:SNP (human) |
RGD |
PMID:18547625 |
RGD:4889528 |
NCBI chrNW_004936482:6,562,396...6,565,003
|
|
G |
Tlr2 |
toll like receptor 2 |
susceptibility severity |
ISO |
DNA:SNP: :rs3804100 (human) DNA:SNP: :rs4696480 (human) DNA:polymorphism:cds:p.R753Q(human) DNA:SNP: :rs7656411 (human) DNA:SNP: :596T>C (human) |
RGD |
PMID:18202345 PMID:18787777 PMID:19096003 PMID:19148143 PMID:20685742 PMID:20815312 PMID:22402138 More...
|
RGD:2312679 RGD:4144171 RGD:4144228 RGD:4145334 RGD:4145343 RGD:4145352 RGD:7800732 |
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
|
|
G |
Tlr3 |
toll like receptor 3 |
no_association |
ISO |
DNA:snp:cds:p.L412F (human) Asthma, Virus-Induced; mRNA:increased expression:sputum (human) |
RGD |
PMID:14987294 PMID:17434873 PMID:17610940 PMID:21129050 PMID:21364926 |
RGD:5128500 RGD:5129226 RGD:5129475 RGD:5129478 RGD:5129493 |
NCBI chrNW_004936554:3,370,766...3,388,125
Ensembl chrNW_004936554:3,369,469...3,385,907
|
|
G |
Tlr4 |
toll like receptor 4 |
severity susceptibility no_association |
ISO |
DNA:polymorphisms:cds:c.896A>G, 1196C>T (human) DNA:Polymorphism:cds:p.D299G (human) DNA:SNPs:: DNA:SNPs: :rs10983755, rs1927914 (human) protein:decreased expression:leukocytes, mononuclear |
RGD |
PMID:15356557 PMID:16266379 PMID:19067129 PMID:19159017 PMID:19330007 PMID:20628601 PMID:20685742 More...
|
RGD:4144141 RGD:4144171 RGD:4144176 RGD:4144188 RGD:4144190 RGD:4144198 RGD:4144817 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tlr6 |
toll like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) DNA:SNP (human) |
RGD |
PMID:15266299 PMID:18547625 |
RGD:4889528 RGD:4889538 |
NCBI chrNW_004936482:6,607,723...6,610,161
Ensembl chrNW_004936482:6,607,753...6,610,143
|
|
G |
Tnc |
tenascin C |
|
ISO |
DNA:SNPs: :multiple (human) DNA:SNP:exon:p.L1677I (human) CTD Direct Evidence: marker/mechanism protein:increased expression:bronchus basement membrane |
RGD CTD |
PMID:9310019 PMID:16115819 PMID:17125141 PMID:18305139 |
RGD:4889565 RGD:4889569 RGD:4889572 RGD:4889589 |
NCBI chrNW_004936487:4,172,263...4,256,780
Ensembl chrNW_004936487:4,172,886...4,233,126
|
|
G |
Tnf |
tumor necrosis factor |
no_association susceptibility |
ISO |
DNA:polymorphism:promoter: ClinVar Annotator: match by term: Asthma, susceptibility to |
RGD OMIM ClinVar |
PMID:8056188 PMID:9818939 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12485196 PMID:12530118 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16720636 PMID:16865291 PMID:16909270 PMID:18050183 PMID:18713756 PMID:19365401 PMID:22760475 PMID:22992668 More...
|
RGD:4143254 |
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:20484920 |
RGD:5131201 |
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
|
|
G |
Tnip1 |
TNFAIP3 interacting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24453940 |
|
NCBI chrNW_004936647:3,914,887...3,959,698
Ensembl chrNW_004936647:3,914,887...3,959,672
|
|
G |
Trpa1 |
transient receptor potential cation channel subfamily A member 1 |
severity |
ISO |
CTD Direct Evidence: marker/mechanism ovalbumin sensitization |
CTD RGD |
PMID:19458046 PMID:31969645 |
RGD:127285811 |
NCBI chrNW_004936648:1,094,460...1,141,394
Ensembl chrNW_004936648:1,094,460...1,141,394
|
|
G |
Tslp |
thymic stromal lymphopoietin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21804549 |
|
NCBI chrNW_004936531:5,495,872...5,500,462
|
|
G |
Ucn |
urocortin |
|
ISO |
associated with Hypersensitivity;mRNA, protein:increased expression:lung |
RGD |
PMID:16427607 |
RGD:1642781 |
NCBI chrNW_004936493:5,258,574...5,260,692
Ensembl chrNW_004936493:5,260,219...5,260,602
|
|
G |
Uts2 |
urotensin 2 |
|
ISO |
|
RGD |
PMID:17045018 |
RGD:2306832 |
NCBI chrNW_004936623:2,339,259...2,345,717
Ensembl chrNW_004936623:2,340,778...2,345,700
|
|
G |
Vdr |
vitamin D receptor |
no_association |
ISO |
DNA:SNPs: :multiple (human) DNA:SNPs (human) DNA:SNP (human) DNA:SNP: :rs7975232 (human) |
RGD |
PMID:15282200 PMID:19622139 PMID:20124605 PMID:21103062 |
RGD:4889854 RGD:4889866 RGD:4889867 RGD:4889868 |
NCBI chrNW_004936512:5,741,836...5,800,999
Ensembl chrNW_004936512:5,740,748...5,801,109
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:sputum |
CTD RGD |
PMID:11907124 PMID:15201500 PMID:19178538 PMID:19263519 |
RGD:6892723 |
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
|
RGD |
PMID:16782752 PMID:21419198 |
RGD:5685381 RGD:5685620 |
NCBI chrNW_004936489:5,425,778...5,434,483
Ensembl chrNW_004936489:5,425,726...5,434,785
|
|
G |
Wdr36 |
WD repeat domain 36 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19198610 |
|
NCBI chrNW_004936531:5,513,082...5,546,515
Ensembl chrNW_004936531:5,513,082...5,548,501
|
|
|
G |
LOC101964975 |
interleukin-8 |
treatment |
ISO |
|
RGD |
PMID:30059697 |
RGD:39939057 |
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
treatment |
ISO |
|
RGD |
PMID:25530546 |
RGD:11081163 |
NCBI chrNW_004936543:2,414,948...2,416,922
Ensembl chrNW_004936543:2,414,850...2,416,953
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
treatment |
ISO |
|
RGD |
PMID:23933317 |
RGD:40903070 |
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Epx |
eosinophil peroxidase |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:11846868 |
RGD:13506893 |
NCBI chrNW_004936490:4,876,857...4,887,275
Ensembl chrNW_004936490:4,876,877...4,887,275
|
|
G |
Il25 |
interleukin 25 |
treatment |
ISO |
|
RGD |
PMID:17889290 |
RGD:40902975 |
NCBI chrNW_004936722:997,476...1,000,881
Ensembl chrNW_004936722:996,960...1,003,201
|
|
G |
LOC101958908 |
HLA class II histocompatibility antigen, DP alpha 1 chain |
susceptibility |
ISO |
DNA:polymorphism: |
RGD |
PMID:28380482 |
RGD:13506910 |
NCBI chrNW_004936476:25,743,512...25,750,809
Ensembl chrNW_004936476:25,743,456...25,750,907
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
DNA:polymorphism: |
RGD |
PMID:28380482 |
RGD:13506910 |
NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
exacerbates |
ISO |
|
RGD |
PMID:21592044 |
RGD:126928124 |
NCBI chrNW_004936476:18,577,825...18,583,675
Ensembl chrNW_004936476:18,574,381...18,583,647
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chrNW_004936994:158,621...171,597
Ensembl chrNW_004936994:158,620...171,601
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20022477 PMID:20485159 |
RGD:4145619 |
NCBI chrNW_004936596:223,660...224,739
Ensembl chrNW_004936596:223,660...224,739
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) |
CTD RGD |
PMID:15970796 PMID:16502481 PMID:20485159 |
RGD:5144000 |
NCBI chrNW_004936565:1,917,970...1,919,027
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chrNW_004936626:3,980,311...4,147,042
Ensembl chrNW_004936626:3,982,647...4,159,976
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chrNW_004936739:975,494...978,426
Ensembl chrNW_004936739:975,493...978,482
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936581:2,743,133...2,751,925
Ensembl chrNW_004936581:2,744,881...2,751,925
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chrNW_004936472:31,644,778...31,677,572
Ensembl chrNW_004936472:31,644,778...31,677,572
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936581:2,069,355...2,072,535
Ensembl chrNW_004936581:2,067,546...2,070,893
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15496426 |
|
NCBI chrNW_004936697:2,440,943...2,453,897
Ensembl chrNW_004936697:2,440,901...2,453,975
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936664:487,069...489,328
Ensembl chrNW_004936664:487,125...489,414
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:mast cell |
CTD RGD |
PMID:9487340 PMID:16502481 PMID:20485159 |
RGD:5143936 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chrNW_004936476:25,913,699...25,923,419
Ensembl chrNW_004936476:25,913,663...25,923,427
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004936490:13,546,405...13,558,635
Ensembl chrNW_004936490:13,546,292...13,558,635
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :795T>C (human) |
CTD RGD |
PMID:15898979 PMID:16502481 PMID:20485159 |
RGD:11059537 |
NCBI chrNW_004936588:2,040,712...2,044,635
Ensembl chrNW_004936588:2,040,630...2,045,110
|
|
|
G |
LOC101969065 |
mamu class II histocompatibility antigen, DR alpha chain |
susceptibility |
ISO |
DNA:SNPs,haplotype:introns: |
RGD |
PMID:22391069 |
RGD:13506908 |
NCBI chrNW_004936727:540,225...544,968
Ensembl chrNW_004936727:540,217...545,036
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma and nasal polyps |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004936490:13,546,405...13,558,635
Ensembl chrNW_004936490:13,546,292...13,558,635
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:17959182 PMID:21558275 PMID:25741868 PMID:30643255 |
|
NCBI chrNW_004936677:3,232,183...3,241,307
Ensembl chrNW_004936677:3,232,183...3,241,253
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936739:975,494...978,426
Ensembl chrNW_004936739:975,493...978,482
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
OMIM CTD |
|
|
NCBI chrNW_004936697:2,440,943...2,453,897
Ensembl chrNW_004936697:2,440,901...2,453,975
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar OMIM |
PMID:25741868 |
|
NCBI chrNW_004936490:13,546,405...13,558,635
Ensembl chrNW_004936490:13,546,292...13,558,635
|
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
exacerbates |
ISO |
associated with respiratory syncytial virus infectious disease;DNA:SNPs:protomer: (rs2233409) (human) |
RGD |
PMID:23487427 |
RGD:40902982 |
NCBI chrNW_004936494:9,537,793...9,541,187
Ensembl chrNW_004936494:9,537,008...9,541,612
|
|
|
G |
Ngf |
nerve growth factor |
treatment |
ISO |
|
RGD |
PMID:30681402 |
RGD:405100716 |
NCBI chrNW_004936627:635,784...641,290
Ensembl chrNW_004936627:635,788...645,364
|
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
severity |
ISO |
protein:increased expression:sputum (human) |
RGD |
PMID:25936567 |
RGD:11531115 |
NCBI chrNW_004936543:2,414,948...2,416,922
Ensembl chrNW_004936543:2,414,850...2,416,953
|
|
G |
Epx |
eosinophil peroxidase |
treatment |
ISO |
|
RGD |
PMID:28751233 |
RGD:13506890 |
NCBI chrNW_004936490:4,876,857...4,887,275
Ensembl chrNW_004936490:4,876,877...4,887,275
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:10984370 |
RGD:4890423 |
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (human) |
RGD |
PMID:19996575 |
RGD:4892021 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
|
RGD |
PMID:8630576 |
RGD:5147837 |
NCBI chrNW_004936556:1,266,621...1,421,271
Ensembl chrNW_004936556:1,266,613...1,421,275
|
|
|
G |
Acsl3 |
acyl-CoA synthetase long chain family member 3 |
|
ISO |
|
RGD |
PMID:23526225 |
RGD:13831300 |
NCBI chrNW_004936569:4,774,602...4,842,906
Ensembl chrNW_004936569:4,774,542...4,844,494
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Cd86 |
CD86 molecule |
treatment |
ISO |
|
RGD |
PMID:25344652 |
RGD:11354965 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
|
RGD |
PMID:29713367 |
RGD:13792581 |
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Il23a |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:19935773 PMID:26344076 |
RGD:11251537 RGD:5037240 |
NCBI chrNW_004936646:743,630...745,998
Ensembl chrNW_004936646:743,688...745,836
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33075463 |
|
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
|
|
G |
Cdh17 |
cadherin 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25918132 |
|
NCBI chrNW_004936544:7,156,213...7,208,392
Ensembl chrNW_004936544:7,156,213...7,205,127
|
|
G |
Herc2 |
HECT and RLD domain containing E3 ubiquitin protein ligase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25918132 |
|
NCBI chrNW_004936471:38,419,147...38,606,312
Ensembl chrNW_004936471:38,419,129...38,606,323
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
susceptibility |
ISO |
DNA:SNP: : rs928976(human) |
RGD |
PMID:24709764 |
RGD:13506912 |
NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145
|
|
G |
LOC101963482 |
HLA class II histocompatibility antigen, DO alpha chain |
treatment |
ISO |
DNA:SNP: :rs3128935(human) |
RGD |
PMID:24709764 |
RGD:13506912 |
NCBI chrNW_004936476:25,786,322...25,790,881
Ensembl chrNW_004936476:25,787,492...25,790,950
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27504716 |
|
NCBI chrNW_004936481:3,559,377...3,689,797
Ensembl chrNW_004936481:3,559,358...3,689,833
|
|
G |
Prkca |
protein kinase C alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27504716 |
|
NCBI chrNW_004936541:6,231,604...6,488,201
Ensembl chrNW_004936541:6,233,110...6,488,052
|
|
G |
Prkd1 |
protein kinase D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27504716 |
|
NCBI chrNW_004936494:4,469,092...4,601,183
Ensembl chrNW_004936494:4,469,089...4,601,214
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004936487:10,745,465...10,758,812
Ensembl chrNW_004936487:10,745,327...10,758,823
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Tenm3 |
teneurin transmembrane protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25918132 |
|
NCBI chrNW_004936554:6,180,883...6,871,178
Ensembl chrNW_004936554:6,183,722...6,619,982
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25721048 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
|
ISO |
ClinVar Annotator: match by term: Platelet-activating factor acetylhydrolase deficiency |
ClinVar OMIM |
PMID:8675689 PMID:9412624 PMID:10194471 PMID:10733466 PMID:16787988 PMID:25741868 PMID:28406212 More...
|
|
NCBI chrNW_004936476:13,609,847...13,646,174
Ensembl chrNW_004936476:13,609,374...13,649,998
|
|
|
G |
Ifng |
interferon gamma |
resistance |
ISO |
|
RGD |
PMID:20817868 |
RGD:4145651 |
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:9927362 |
RGD:4143184 |
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:10934091 |
RGD:4890960 |
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:10731862 |
RGD:5130994 |
NCBI chrNW_004936490:4,809,773...4,819,070
Ensembl chrNW_004936490:4,809,631...4,819,070
|
|